186 related articles for article (PubMed ID: 30968304)
21. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of hot-melt extrusion technique in the preparation of HPC matrices for prolonged release.
Loreti G; Maroni A; Del Curto MD; Melocchi A; Gazzaniga A; Zema L
Eur J Pharm Sci; 2014 Feb; 52():77-85. PubMed ID: 24211649
[TBL] [Abstract][Full Text] [Related]
23. The use of agar as a novel filler for monolithic matrices produced using hot melt extrusion.
Lyons JG; Devine DM; Kennedy JE; Geever LM; O'Sullivan P; Higginbotham CL
Eur J Pharm Biopharm; 2006 Aug; 64(1):75-81. PubMed ID: 16697170
[TBL] [Abstract][Full Text] [Related]
24. Properties of sustained-release tablets prepared by hot-melt extrusion.
Zhang F; McGinity JW
Pharm Dev Technol; 1999 May; 4(2):241-50. PubMed ID: 10231885
[TBL] [Abstract][Full Text] [Related]
25. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion.
Roblegg E; Jäger E; Hodzic A; Koscher G; Mohr S; Zimmer A; Khinast J
Eur J Pharm Biopharm; 2011 Nov; 79(3):635-45. PubMed ID: 21801834
[TBL] [Abstract][Full Text] [Related]
26. A novel floating controlled release drug delivery system prepared by hot-melt extrusion.
Vo AQ; Feng X; Morott JT; Pimparade MB; Tiwari RV; Zhang F; Repka MA
Eur J Pharm Biopharm; 2016 Jan; 98():108-21. PubMed ID: 26643801
[TBL] [Abstract][Full Text] [Related]
27. Preparation of sustained release co-extrudates by hot-melt extrusion and mathematical modelling of in vitro/in vivo drug release profiles.
Quintavalle U; Voinovich D; Perissutti B; Serdoz F; Grassi G; Dal Col A; Grassi M
Eur J Pharm Sci; 2008 Mar; 33(3):282-93. PubMed ID: 18280119
[TBL] [Abstract][Full Text] [Related]
28. Solid lipid extrusion of sustained release dosage forms.
Reitz C; Kleinebudde P
Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
[TBL] [Abstract][Full Text] [Related]
29. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions.
Andrews GP; Abu-Diak O; Kusmanto F; Hornsby P; Hui Z; Jones DS
J Pharm Pharmacol; 2010 Nov; 62(11):1580-90. PubMed ID: 21072971
[TBL] [Abstract][Full Text] [Related]
30. Sustained-Release Solid Dispersion of High-Melting-Point and Insoluble Resveratrol Prepared through Hot Melt Extrusion to Improve Its Solubility and Bioavailability.
Zhu W; Fan W; Zhang X; Gao M
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443569
[TBL] [Abstract][Full Text] [Related]
31. Hot-melt extrusion of polyvinyl alcohol for oral immediate release applications.
De Jaeghere W; De Beer T; Van Bocxlaer J; Remon JP; Vervaet C
Int J Pharm; 2015 Aug; 492(1-2):1-9. PubMed ID: 26160667
[TBL] [Abstract][Full Text] [Related]
32. Mechanical properties and drug release of venlafaxine HCl solid mini matrices prepared by hot-melt extrusion and hot or ambient compression.
Avgerinos T; Kantiranis N; Panagopoulou A; Malamataris S; Kachrimanis K; Nikolakakis I
Drug Dev Ind Pharm; 2018 Feb; 44(2):338-348. PubMed ID: 29023145
[TBL] [Abstract][Full Text] [Related]
33. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
[TBL] [Abstract][Full Text] [Related]
34. Sustained release solid lipid matrices processed by hot-melt extrusion (HME).
Vithani K; Maniruzzaman M; Slipper IJ; Mostafa S; Miolane C; Cuppok Y; Marchaud D; Douroumis D
Colloids Surf B Biointerfaces; 2013 Oct; 110():403-10. PubMed ID: 23759381
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
[TBL] [Abstract][Full Text] [Related]
37. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
[TBL] [Abstract][Full Text] [Related]
38. Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process.
Lyons JG; Hallinan M; Kennedy JE; Devine DM; Geever LM; Blackie P; Higginbotham CL
Int J Pharm; 2007 Feb; 329(1-2):62-71. PubMed ID: 17010544
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the hyperbranched polymer Hybrane H1500 for production of matricial controlled-release particles by hot-melt extrusion.
Raviña-Eirín E; Sánchez-Rodríguez B; Gómez-Amoza JL; Martínez-Pacheco R
Int J Pharm; 2014 Jan; 461(1-2):469-77. PubMed ID: 24368108
[TBL] [Abstract][Full Text] [Related]
40. Tailor-made release triggering from hot-melt extruded complexes of basic polyelectrolyte and poorly water-soluble drugs.
Kindermann C; Matthée K; Strohmeyer J; Sievert F; Breitkreutz J
Eur J Pharm Biopharm; 2011 Oct; 79(2):372-81. PubMed ID: 21596136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
